LEUKOCYTE ADHESION DEFICIENCY
Clinical trials for LEUKOCYTE ADHESION DEFICIENCY explained in plain language.
Never miss a new study
Get alerted when new LEUKOCYTE ADHESION DEFICIENCY trials appear
Sign up with your email to follow new studies for LEUKOCYTE ADHESION DEFICIENCY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Hope for kids with rare 'sticky blood' disease: new drug enters final testing
Disease control Recruiting nowThis study tests an experimental drug called AVTX-803 in people with leukocyte adhesion deficiency type II (LAD II), a rare genetic condition that weakens the immune system and leads to repeated, hard-to-treat infections. The trial will compare the drug against a period without t…
Matched conditions: LEUKOCYTE ADHESION DEFICIENCY
Phase: PHASE3 • Sponsor: AUG Therapeutics • Aim: Disease control
Last updated May 26, 2026 12:02 UTC
-
Rare immune disorder drug tested for long-term safety in tiny study
Disease control Recruiting nowThis study looks at the long-term safety of a drug called AVTX-803 for people with leukocyte adhesion deficiency type II (LAD II), a rare genetic condition that weakens the immune system. Only 2 participants who completed a previous study can join. Researchers will monitor side e…
Matched conditions: LEUKOCYTE ADHESION DEFICIENCY
Phase: PHASE3 • Sponsor: AUG Therapeutics • Aim: Disease control
Last updated May 18, 2026 12:07 UTC